FACULTY
Chronic Pain Management with Opioid Analgesics: A Pharmacist Perspective
Paper Symposium
Activity Date: April 2008  — Activity Info: Volume 5, (1)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 

Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR

Michelle M. Zingone, PharmD, BCPS
Assistant Professor
University of Tennessee College of Pharmacy
Knoxville, Tennessee
Dr Zingone reports having no significant financial or advisory relationships with corporate organizations related to this activity.

PARTICIPATING FACULTY

Ewan McNicol, RPh, MS
Assistant Professor of Anesthesiology
Tufts University School of Medicine
New England Medical Center
Boston, Massachusetts
Mr McNicol reports serving as a consultant for Wyeth Pharmaceuticals; and serving as a medical writer for Javelin Pharmaceuticals.

Lynn Webster, MD, FACPM, FASAM
Medical Director
Lifetree Clinical Research and Pain Clinic
Salt Lake City, Utah
Dr Webster reports receiving grants/research support from Advanced Bionic, Alpharma Pharmaceuticals, LLC, CoMentis, Durect, Elan, Elite, Forest Laboratories, GlaxoSmithKline, Jazz, Mallinckrodt, Medtronic, Merck and Company, Neurogesx, Predix, Purdue, Takeda, Torreypines, and Zars; serving as a consultant for Advanced Bionic, Cephalon, Elan, King Pharmaceuticals, and Medtronic; and receiving honoraria from Advanced Bionic, Cephalon, Elan, and King Pharmaceuticals.

Notice: In accordance with ACPE Criteria for Quality, the audience is advised that an article in this CE activity contains reference(s) to unlabeled or unapproved uses of drugs or devices.

McNicol–alvimopan, butorphanol, caffeine, chlorpromazine, ketamine, methylnaltrexone, and methylphenidate.

University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?